NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

Christopher Alvarez‐Breckenridge, Jianhua Yu, Richard L. Price, +15

Nature Medicine

Neuro-oncologyGliomaMedicineImmunologyCell Death +7

Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

Fengting Yan, Lapo Alinari, Mark Lustberg, +31

Cancer Research

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Ji Young Yoo, Alena Cristina Jaime‐Ramirez, Chelsea Bolyard, +14

Clinical Cancer Research

Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma

Amy Haseley, Sean Boone, Jeffrey Wojton, +7

Cancer Research

ImmunologyImmunoeditingImmunotherapeuticsCancer BiologyGlioma +16

Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma

Jeffrey Wojton, Zhengtao Chu, Haritha Mathsyaraja, +11

Molecular Therapy

Aurora-A Inhibition Offers a Novel Therapy Effective against Intracranial Glioblastoma

James R. Van Brocklyn, Jeffrey Wojton, Walter H. Meisen, +4

Cancer Research

Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide

Alena Cristina Jaime‐Ramirez, Nina Dmitrieva, Ji Young Yoo, +6

The Journal of Gene Medicine

Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Ji Young Yoo, Jason Pradarelli, Amy Haseley, +12

Clinical Cancer Research

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Chelsea Bolyard, Walter H. Meisen, Yeshavanth Banasavadi‐Siddegowda, +20

Clinical Cancer Research

How to train glioma cells to die: molecular challenges in cell death

Jeffrey Wojton, Walter H. Meisen, Balveen Kaur

Journal of Neuro-Oncology